Issued Patents 2021
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11111229 | Tetrahydroquinoline compositions as BET bromodomain inhibitors | Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke, Matthew W. Martin +3 more | 2021-09-07 |
| 11084831 | Benzopiperazine compositions as BET bromodomain inhibitors | Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke, Matthew W. Martin +4 more | 2021-08-10 |
| 10995078 | Compounds and compositions for inhibition of FASN | David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu, Matthew W. Martin +3 more | 2021-05-04 |
| 10988450 | 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more | 2021-04-27 |
| 10988441 | Alpha-cinnamide compounds and compositions as HDAC8 inhibitors | Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu, Matthew W. Martin +5 more | 2021-04-27 |
| 10913753 | Thienopyridine carboxamides as ubiquitin-specific protease inhibitors | David Joseph Guerin, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr., Hongbin Li +6 more | 2021-02-09 |
| 10889592 | Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors | David Joseph Guerin, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr., Hongbin Li +6 more | 2021-01-12 |